Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	28.97	46.8	189.73	72.03	41.9
Short-Term Investments	78.79	84.13	0	0	34.84
Cash & Cash Equivalents	107.77	130.93	189.73	72.03	76.74
Cash Growth	-17.69%	-30.99%	163.39%	-6.13%	84.91%
Receivables	0	0	0	0.14	1.13
Other Current Assets	1.83	0.45	0.75	2.67	1.94
Total Current Assets	109.6	131.38	190.48	74.84	79.81
Property, Plant & Equipment	14.66	16.07	0.24	0.14	0.07
Long-Term Investments	17.63	5.62	1.63	0	0
Other Long-Term Assets	2.14	2.19	2.19	0.95	0.96
Total Long-Term Assets	34.43	23.89	4.07	1.08	1.03
Total Assets	144.03	155.27	194.54	75.93	80.84
Accounts Payable	3.7	1.95	7.13	7.88	3.55
Deferred Revenue	0	0	0	12.38	0
Current Debt	1.25	0.53	0	0	0
Other Current Liabilities	6.53	4.5	7.67	1.8	6.98
Total Current Liabilities	11.47	6.99	14.8	22.06	10.53
Long-Term Debt	44.76	16	0	0	0
Other Long-Term Liabilities	0	0	0	10.23	0.29
Total Long-Term Liabilities	44.76	16	0	10.23	0.29
Total Liabilities	56.23	22.99	14.8	32.29	10.82
Total Debt	46	16.54	0	0	0
Debt Growth	178.20%	-	-	-	-
Retained Earnings	-277.87	-225.53	-171.36	-294.19	-213.16
Comprehensive Income	0	-0.04	0	0	0
Shareholders' Equity	87.8	132.27	179.75	43.63	70.02
Net Cash / Debt	61.76	114.4	189.73	72.03	76.74
Net Cash / Debt Growth	-46.01%	-39.71%	163.39%	-6.13%	84.91%
Net Cash Per Share	0.88	1.62	2.79	1.23	1.96
Working Capital	98.12	124.39	175.68	52.78	69.28
Book Value Per Share	1.24	1.88	2.66	0.75	1.79

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).